Adial Pharmaceuticals, Inc.
ADIL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001513525
In the last 90 days, Adial Pharmaceuticals, Inc. insiders filed 2 open-market purchases and 0 sales; 17 institutions reported holding it in 13F filings for Q2 2026, worth $334.6K in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Adial Pharmaceuticals, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 15 | 17 | +2 |
| Shares | 35.6K | 136.5K | +100.8K (+283.0%) |
| Value | $63.8K | $334.6K | +$270.8K (+424.6%) |
New holders (4)
Institutions that held Adial Pharmaceuticals, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 32,119 | $82.2K | 0.00% |
| Citadel Advisors LLC | 29,547 | $75.6K | 0.00% |
| StoneX Group Inc. | 19,699 | $35.7K | 0.00% |
| China Universal Asset Management Co., Ltd. | 8,000 | $20.5K | 0.00% |
Sold out (2)
Institutions that held Adial Pharmaceuticals, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Caitong International Asset Management Co., Ltd | 15 | $27 |
| Northwestern Mutual Wealth Management Co | 4 | $7 |